Social disparities and the COVID-19, influenza, and RSV ‘tripledemic’ in Ontario, Canada: a population-based study
Mitchell E, Zhu H, Fitzpatrick T, Majoe A, Sule NO, Guglielmi R, Butt ZA. Epidemiol Infect. 2026 Sep 24; 154:e117.
Publications
The effectiveness of the palivizumab programme in reducing the risk of paediatric asthma: a population-based study in Ontario, Canada
Foley KA, Buchan SA, McNally D, Dimitris M, Swayze S, Kwong JC, Hawken S, Saxena S, Hargreaves D, Fitzpatrick T. Paediatr Perinat Epidemiol. 2026; Mar 31 [Epub ahead of print].
Pediatric acute respiratory virus hospitalizations: a population-based cohort study, 2017-2024
Fitzpatrick T, Buchan SA, Mahant S, Fu L, Kwong JC, Stukel TA, Guttmann A. J Infect Dis. 2025; jiaf212. Epub 2025 Apr 26.
Burden of illness associated with respiratory syncytial virus, influenza, and coronavirus disease 2019 in infants and young children in Ontario, Canada, 2018-2023: a population-based Canadian Immunization Research Network study
Jorgensen SCJ, Hernandez A, Buchan SA, Fitzpatrick T, Guttmann A, Morris SK, Kwong JC. Open Forum Infect Dis. 2024; 11(10):ofae601.
Pediatric respiratory syncytial virus hospitalizations, 2017-2023
Fitzpatrick T, Buchan SA, Mahant S, Fu L, Kwong JC, Stukel TA, Guttmann A. JAMA Netw Open. 2024; 7(6):e2416077. Epub 2024 Jun 11.
School reopening and COVID-19 in the community: evidence from a natural experiment in Ontario, Canada
Fitzpatrick T, Wilton A, Cohen E, Rosella L, Guttmann A. Health Aff. 2022; 41(6):864-72. Epub 2022 Jun 6.
SARS-CoV-2 infection among maternal-infant dyads in Ontario, Canada
Fitzpatrick T, Wilton AS, Chung H, Guttmann A. JAMA Netw Open. 2021; 4(8):e2120150. Epub 2021 Aug 9.
Challenges of using asthma admission rates as a measure of primary care quality in children: an international comparison
Lut I, Lewis K, Wijlaars L, Gilbert R, Fitzpatrick T, Lu H, Guttmann A, Goldfield S, Lei S, Gunnlaugsson G, Jónsson SH, Mechtler R, Gissler M, Hjern A, Hardelid P. J Health Serv Res Policy. 2021; 26(4):251-62. Epub 2021 Jul 28.
Family and child risk factors for early-life RSV illness
Fitzpatrick T, McNally JD, Stukel TA, Lu H, Fisman D, Kwong JC, Guttmann A. Pediatrics. 2021; 147(3):e2020029090. Epub 2021 Mar 18.
Palivizumab’s real-world effectiveness: a population-based study in Ontario, Canada, 1993–2017
Fitzpatrick T, McNally JD, Stukel TA, Kwong JC, Wilton AS, Fisman D, Guttmann A. Arch Dis Child. 2021; 106(2):173-9. Epub 2020 Aug 28.